Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$734.06
-1.39%
Mkt Cap $77.87B
Analyst Ratings
Buy
14
Hold
8
Sell
0
Price Target (115 analysts)
$862.74
Range $700.00 – $1,057.00
Implied Upside
+17.5%
Consensus $862.74 vs current $734.06